-
Signature
-
/s/ Kathleen P. Bloch attorney-in-fact for Edward R. Jones
-
Stock symbol
-
CTSO
-
Transactions as of
-
Dec 9, 2021
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
12/13/2021, 06:59 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CTSO |
Common Stock |
Options Exercise |
$16.5K |
+4K |
+5.08% |
$4.13 |
82.8K |
Dec 9, 2021 |
Direct |
|
| transaction |
CTSO |
Common Stock |
Tax liability |
-$16.5K |
-3.16K |
-3.82% |
$5.22 |
79.6K |
Dec 9, 2021 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CTSO |
Stock Option (right to buy) |
Options Exercise |
$0 |
-4K |
-100% |
$0.00* |
0 |
Dec 9, 2021 |
Common Stock |
4K |
$4.13 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
1. Includes: (i) the following Restricted Stock Units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 10,339 shares of the Issuer's common stock owned by the reporting person, inclusive of the shares acquired after giving effect to the transactions reported on this Form 4.